Innovent Biologics proposes share mandates, director re-elections, and restricted shares

Innovent Biologics Inc. (HKEX:1801) has announced a series of resolutions to be presented at its upcoming Annual General Meeting (AGM) on June 25, 2025, seeking shareholder approval for key strategic and governance matters. The proposals include the granting of general mandates to buy back shares and issue new shares, the re-election of retiring directors, the re-appointment of the external auditor, and a grant of restricted shares to Dr. De-Chao Michael Yu, Chairman of the Board and Chief Executive Officer.